New Perspectives in the Pharmacological Potential of Naringin in Medicine
Journal:
Current Medicinal Chemistry
Volume:
28
Page:
1987-2007
Author(s):
María Angélica Rivoira, Valeria Rodriguez, Germán Talamoni and Nori Tolosa de Talamoni*
Complications of Muscle Hematomas in Hemophilia
Journal:
Cardiovascular & Hematological Disorders-Drug Targets
Volume:
20
Page:
242-248
Author(s):
E. Carlos Rodriguez-Merchan*
In silico and In vitro Investigation of a Likely Pathway for Anti-Cancerous Effect of Thrombocidin-1 as a Novel Anticancer Peptide
Journal:
Protein & Peptide Letters
Volume:
27
Page:
751-762
Author(s):
Abbas Tanhaian, Elyas Mohammadi, Roghayyeh Vakili-Ghartavol, Mohammad Reza Saberi, Mehdi Mirzayi* and Mahmoud Reza Jaafari*
Nanoparticle-based Drug Delivery Systems for Targeted Epigenetics Cancer Therapy
Journal:
Current Drug Targets
Volume:
21
Page:
1084-1098
Author(s):
Fengqian Chen, Yunzhen Shi, Jinming Zhang and Qi Liu*
Meet Our Editorial Board Member
Journal:
Combinatorial Chemistry & High Throughput Screening
Volume:
23
Page:
357-358
Author(s):
Won-Kyo Jung
Association of GRP78, HIF-1α and BAG3 Expression with the Severity of Chronic Lymphocytic Leukemia
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
20
Page:
429-436
Author(s):
Roghayeh Ijabi, Parisa Roozehdar, Reza Afrisham, Hemen Moradi-Sardareh, Saeed Kaviani, Janat Ijabi* and Amirhossein Sahebkar
A Comprehensive Review of the Genus Pyrola Herbs in Traditional Uses, Phytochemistry and Pharmacological Activities
Journal:
Current Topics in Medicinal Chemistry
Volume:
20
Page:
57-77
Author(s):
Xiliang Yang*, Jianglian She, Jinping Liu, Tao Yang, Gege An, Qingru Chen, Cheng Fan, Shuangjun Li, Qian Liu, Chunguo Qian, Ying Liu, Yajie zhou and Jingyi Zhao
New Promises to Cure Cancer and Other Genetic Diseases/Disorders: Epi-drugs Through Epigenetics
Journal:
Current Topics in Medicinal Chemistry
Volume:
19
Page:
972-994
Author(s):
Yong-Tao Duan, Chetan B. Sangani*, Wei Liu, Kunjal V. Soni and Yongfang Yao*
Novel Benzo[B]Furans with Anti-Microtubule Activity Upregulate Expression of Apoptotic Genes and Arrest Leukemia Cells in G2/M Phase
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
19
Page:
375-388
Author(s):
Karolina Królewska-Golińska, Marcin J. Cieślak*, Milena Sobczak, Rafał Dolot, Ewa Radzikowska-Cieciura, Mariola Napiórkowska, Iwona Wybrańska and Barbara Nawrot
Enasidenib: First Mutant IDH2 Inhibitor for the Treatment of Refractory and Relapsed Acute Myeloid Leukemia
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
18
Page:
1936-1951
Author(s):
Raghav Dogra, Rohit Bhatia, Ravi Shankar, Parveen Bansal and Ravindra K. Rawal*